Showing results (1321-1330 of 1,431) with videos related to

Sort By:
Pageof 144
Oncogene|April 30, 2013
LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodelingJ J-C Sheu, C-C Lee, C-H Hua, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetesH J Kim, J Y Lee, H S Jung, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factorsAnne W M Lee, W T Ng, W M Hung, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 28, 2014
Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasisJ-K Lee, J Lee, S S Park, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|August 26, 2003
Infection control for SARS in a tertiary neonatal centreP C Ng, K W So, T F Leung, et al.
Singapore Medical Journal|March 6, 2002
A window on the current status of diabetes mellitus in Singapore--the Diabcare-Singapore 1998 studyW R Lee, H S Lim, A C Thai, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitorY S Oh, M Yun, S Y Hwang, et al.
Singapore Medical Journal|March 6, 2002
The status of diabetes mellitus in primary care institution and restructured hospitals in SingaporeW R Lee, S Emmanuel, H S Lim, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the ratE A Kowaluk, J Mikusa, C T Wismer, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitorsM Cowart, C H Lee, G A Gfesser, et al.
Pageof 144